The International Journal of Biochemistry & Cell Biology
Medicine in focusRevisiting the seed and soil in cancer metastasis
Introduction
The cause of death for the vast majority of cancer patients is the development of metastatic lesions at sites distant from that of the primary tumor. Metastasis describes both the process of cancer spread (i.e. the verb, describing the events that characterize the spread of cancer) and the resultant secondary cancer (i.e. noun, describing the actual metastatic lesion). Since most cancer patients present with localized disease that is effectively managed with multimodality therapies including surgery, radiation, and chemotherapy, the development of metastasis at distant secondary organs must involve the dissemination of metastatic cells before patients present with a primary tumor. Based on the work of several groups, it is believed that the process of metastasis (i.e. the verb) involves tumor cells leaving the primary tumor through a well-regulated lysis of surrounding stroma. These cells must pass through the tumor basement membrane and then through or between endothelial cells in order to enter the circulation. While in the circulation, a tumor cells must resist the process of anoikis (programmed cell death associated with loss of cellular contact), evade immune recognition, cope with the sheer physical stress of the circulatory system, and eventually arrest at a distant organ. At the distant site, the cell must exit the circulation, survive the stresses of a new and likely hostile microenvironment, proliferate, induce angiogenesis and/or co-opt existing blood vessels, and then successfully grow into a measurable metastatic lesion (Steeg and Theodorescu, 2008).
The timing, pattern and sites for the spread of cancer are in part defined by the specific cancer type. The route of spread of cancer may include blood stream (hematogenous), lymphatic vessels, or third space extension (i.e. ascitic fluid dissemination as seen in ovarian cancer). The site of distant metastasis may include regional lymph nodes, or visceral organs such as lungs, liver, brain, and bone. While Weiss et al. (1988) have shown that the primary site of metastases tends to occur at the first capillary bed encountered, it is increasingly believed that the specific site of distant metastasis is not simply to be due to anatomic location of the primary tumor or proximity to secondary sites but rather, involves interactions between tumor cells and the local microenvironment at the secondary site.
For many reasons, metastatic lesions are often not amenable to the surgical cures achieved in the management of the primary tumor. First, the development of metastases at distant secondary organs is often so widespread that surgery is not possible. In addition, the organs in which metastases develop may not be able to accommodate the necessary wide surgical margins needed for cure (i.e. brain). For many cancers, metastatic lesions themselves demonstrate increased resistance to conventional treatment modalities (i.e. chemotherapy). This resistance to therapy may be acquired as a result of past treatment of the patient or may be an innate feature of cells that have successfully negotiated the metastatic process. Based on the challenges that metastatic disease presents, new treatment options are needed in order to decrease morbidity and mortality.
Stephen Paget's seed and soil hypothesis suggested that the sites where metastases occur are defined not only by the tumor cell (“seed”) but also the microenvironment of the secondary metastatic site (“soil”). Recent data have shed new light on the acquisition of the “seeds” of metastasis, suggesting that some of the features of this tumor cell phenotype are conveyed early in the process of oncogenesis, whereas others are selected for during cancer progression (Scheel et al., 2007, Talmadge, 2007). Indeed, many of the features of the tumor cells (“seed”) now appear to be shared with primitive stem-like cells capable of not only tumor-initiation but also metastasis (Mehlen and Puisieux, 2006, Croker and Allan, 2008, Vermeulen et al., 2008). An attractive link between the tumor-initiating cell (cancer stem cell) hypothesis and metastasis is the programming and ability of these stem-like, self-renewing and multipotent cells to resist stress, perhaps facilitated by their abilities to engage and develop connections with specific microenvironments (“soil”). In this review we will consider new data that describe the tumor cell, its microenvironment, and connections between the two as a critical means to resist the stresses that cells encounter during metastatic progression.
Section snippets
Characteristics and emergence of the tumor cell (the “seed”)
The emergence of the metastatic phenotype within a primary tumor has been explained as a process that happens late in carcinogenesis. This hypothesis holds that tumor cells possessing the metastatic phenotype represent a very small fraction of cells within a heterogeneous primary tumor and that over time, a small proportion of tumor cells gain the attributes necessary for metastasis (Fidler and Kripke, 1977). In testing of this hypothesis, Varmus and colleagues were able to show untransformed
Acknowledgements
The authors would like to thank Drs. Joseph W. Briggs, Sung-Hyeok Hong, Lalage Wakefield, and Glenn Merlino for helpful comments and critical reading of the manuscript.
References (246)
- et al.
Therapeutic implications of cancer stem cells
Curr Opin Genet Dev
(2004) - et al.
Cell adhesion molecules, signal transduction and cell growth
Curr Opin Cell Biol
(1999) EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans
Cancer Cell
(2006)- et al.
Interleukin-2, interleukin-15, and their roles in human natural killer cells
Adv Immunol
(2005) - et al.
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
Cell
(2005) - et al.
Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein
Exp Cell Res
(2000) - et al.
A perivascular niche for brain tumor stem cells
Cancer Cell
(2007) - et al.
Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy
Mod Pathol
(2002) - et al.
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis
Cell
(2006) - et al.
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
Cell
(2000)